Seres Therapeutics, Inc. Debt Securities, Available-for-sale, Current
Seres Therapeutics, Inc. (MCRB) had Debt Securities, Available-for-sale, Current of $2.40 million as of 2020-06-30, per its 10-Q filed 2020-07-28.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2020-07-28
- 2020-06-30: Debt Securities, Available-for-sale, Current $2.40M.
- 2020-03-31: Debt Securities, Available-for-sale, Current $20.24M.
- 2019-12-31: Debt Securities, Available-for-sale, Current $29.69M.
- 2019-09-30: Debt Securities, Available-for-sale, Current $34.49M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2020-06-30 | $2.40M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $20.24M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $29.69M 10-Q · filed 2020-07-28 |
| 2019-09-30 | $34.49M 10-Q · filed 2019-11-05 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-02 |
| 2018-09-30 | $17.18M 10-Q · filed 2018-11-08 |
| 2017-12-31 | $113.89M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |